GSK pill works in uncomplicated gonorrhea

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hi. Hello. It’s Meghana. Today we’re excited to unveil the 2024 STATUS List, a rundown of the 50 most influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech. Check it out!

The need-to-know this morning

• Viking Therapeutics reported results from a mid-stage study of its obesity drug, called VK2735, showing average weight loss of 13%, adjusted for placebo, after 13 weeks. Gastrointestinal side effects were mild to moderate and discontinuations were equivalent across the placebo and VK2735 arms of the study. Viking’s stock price doubled in pre-market trading.

GSK pill works in uncomplicated gonorrhea

Gepotidacin, an experimental oral antibiotic made by GSK, successfully cleared gonorrhea in patients — performing just as well as a combination of cetriaxone and azithromycin, the standard treatment. Gonorrhea is on the rise, and growing increasingly resistant to antibiotics; it is considered by the WHO as a priority pathogen.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In